Categories
CURRENT TRIALS TRIAL

Suffering from  Moderate to Severe Hidradenitis Suppurativa?

Suffering from  Moderate to Severe Hidradenitis Suppurativa?

Trial – Acrotech

Incyte is conducting a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of XXXXXXXXX in Participants with Moderate to Severe Hidradenitis Suppurativa

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #  INCB- 54707-301

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Mild to Moderate Atopic Dermatitis?

Suffering from Mild to Moderate Atopic Dermatitis?

Trial – Acrotech

Acrotech is conducting an Open-label Study to Assess the Long-Term Safety of XXXXXXXX Ointment in Mild to Moderate Atopic Dermatitis.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # MEDI-MM36-302

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Nail and Scalp Psoriasis?

Suffering from Nail and Scalp Psoriasis?

Trial – Eli Lilly

Eli Lilly is conducting a US-Based Observational Study of Nail and Scalp Psoriasis Improvement in Patients Treated with Ixekizumab (Taltz)

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #  I1F-MC-B018

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Atopic Dermatitis with Skin of Color?

Suffering from Atopic Dermatitis with Skin of Color?

Trial – Eli Lilly

Eli Lilly is conducting an Open-Label Study of XXXXXXXXXX in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-MC-KGBP

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Previously Treated With Dupilumab for Atopic Dermatitis?

Previously Treated With Dupilumab for Atopic Dermatitis?

Trial – Eli Lilly

Eli Lilly is conducting an Open-Label Study of XXXXXXXXXX in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-MC-KGBO

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Atopic Dermatitis?

Suffering from Atopic Dermatitis?

Trial – Syneos Health/Eli Lilly

Eli Lilly and Company are conducting a Long-term Study to Assess the Safety and Efficacy of xxxxxxxxxxx in Patients With Moderate-to-Severe Atopic Dermatitis.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-DM-KGAA/DRM06-AD07

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Hidradenitis Suppurativa Treatment Extension Study

Hidradenitis Suppurativa Treatment Extension Study

Trial –Novartis

A multicenter, double-blind, randomized withdrawal extension study of subcutaneous XXXXXXXXXX to demonstrate long-term efficacy, safety and tolerability in subjects with moderate to severe hidradenitis suppurativa.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # CAIN457M2301E1

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Various Skin Conditions Sample Collection

Various Skin Conditions Sample Collection

Trial -DermTech

A Multi-center Sample Collection Study in Patients with a variety of skin conditions including but not limited to Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma Utilizing DermTech’s Non-invasive Adhesive Patch Biopsy Kits

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # 17-06

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Prurigo Nodularis?

Suffering from Prurigo Nodularis?

Trial -ICON/Trevi

This 1 year study aims to determine the evaluate the safety, tolerability, and effectiveness of nalbuphine as a treatment for the itching related to Prurigo Nodularis (PN). This study will also evaluate participant’s itch-related quality of life and sleep quality. There are currently no approved treatments specifically for people who experience itching due to Prurigo Nodularis.

 

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # TR-11

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Cutaneous Squamous Cell Carcinoma Risk of Recurrence Prediction

Cutaneous Squamous Cell Carcinoma Risk of Recurrence Prediction

Trial – Castle Biosciences

Prospective Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma

To participate in your local study, please contact  (949) 707-5734 or fill out the form below.

CBI_2019_cSCC_PVS_001

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.